Read, learn and get inspired by our insights within the fields of Pharma, Medical Device and IVD. In our blog, we provide useful snippets of information as well as the latest news within our fields. Contact us if your’e interested in a deeper walk-through in any of the subjects.

Interchangeable biological medicines

Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain market share compared to generics, and new biosimilars do not always lead to lower prices.

Read more

“Do we have the right balance between risk and patient benefit?”

Does the introduction of MDR and IVDR mean that we risk losing important medical technology innovations? Do the tightened rules make the certification process so complex that start-up companies simply do not participate and give up, with the result that important innovations that can improve care never reach the market? What can we do in the short term to avoid this happening?

Read more

“The situation is not satisfactory”

One of the more important aims of the EU pharmaceutical legislation is to ensure access to affordable medicines to all patients in the region. A new product, for example to treat cancer, should be available for all EU patients, including those in the smaller member states.

Read more